1[1]Leon MB.A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting[J].N Engl J Med,1998,339:1665.
2[2]Wehinger A.Lipoprotein(a) and coronary thrombosis and restenosis after stent placement[J].J Am Coll Cardiol,1999,33:1005.
3[5]Hasdai D.Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis[J].J Am Coll Cardiol,1996,28:361.
4[6]Fleser A.The current status of stenting:pathobiology Trends[J].Cardiovasc Med,1997,7:24.
5[7]Neumann FJ.Prospective evaluation of hemostatic predictors of subacute stent thrombosis after the palmaz-schatz stenting[J].J Am Coll Cardi-ol,1996,27:15.
6Farb A, Burke AP, Kolodgie FD, et al . Pathological mechanisms of fatal late coronary stent thrombosis in humans[Jl. Circulation,2003,108:1701-1706.
7Frab A, Sangiorgi G, Carter AJ, et al . Pathology of acute and chronic tissue response to coronary stenting in humans[J]. Circulation, 1999,99:44-52.
8Neumarm FJ, Ott I, Gawaz M, et al , Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty[J]. J Am Coll Cardiol, 1996,27:819-824.
9Gawaz M, Neumann FJ, Ott I, et al . Role of activation-dependent platelet membrane glycoproteins in development of subacute occlusive coronary stent thrombosis[J]. Coron Artery Dis, 1997, 8:121-128.
10Neumann FJ, Gawaz M, Ott I, et al . Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schaz stenting[J]. J Am Coil Cardiol, 1996, 27:15-21.
1Kuchulakanti PK,Chu WW,Torguson R,et al. Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eiuting Stents[J]. Circulation,2006,113(8): 1108-1113.
2Orford JL,Lennon R,Melby S,et al. Frequency and correlates of coro-nary stent thrombosis in themodern era: analysis of a single center reg-istry [J]. J Am Coil Cardiol, 2002,40(9): 1567-1572.
3Rodriguez AE, Mieres J, Femandez-Pereira C, et al. Coronary stent thrombosis in the current drug-eluting stent era: insightsfrom the ERAC I Strial [J]. J Am Coil Cardiol, 2006,47(1) : 205-207.
4Gilles Montalescot,MD.,Ph.D,et al. Platelet glycop ro-teiu H b/Ⅲa inhibition with coronary stenting for acute myocardial in-farction [J]. N Engl J Med, 2001,344(2) : 1895 - 1903.
